Which of the GLP-1RAs discussed in the article by Gaw, et al had a significantly increased rate of adverse events?
Semaglutide (Wegovy)
Gaw CE, Hays HL, Kemp CA, et al. Glucagon-Like Peptide-1 Receptor Agonist Cases Reported to United States Poison Centers, 2017-2022. J Med Toxicol. 2024;20(2):193-204. doi:10.1007/s13181-024-00999-x
Contributed by Tatiana Barriga, MD, Emergency Medicine PGY-3 on behalf of the Florida Poison Information Center Network
Posted in Question Of The Day